Agilent Technologies, Inc.
A Healthcare Diagnostics & Research
Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow A
Agilent Technologies, Inc. (A) Net income
Agilent Technologies, Inc.'s net income for fiscal 2025 was $1.3B, unchanged from fiscal 2024. Over the twelve months to 31 July 2026 it was $1.4B. Over the past ten years it has ranged from $316.0M (fiscal 2018) to $1.3B (fiscal 2025) — the current reading is the highest in ten years. Agilent Technologies, Inc. ranks 3rd of 52 Diagnostics & Research companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $1.3B | 1.09% |
| FY2024 | $1.3B | 3.95% |
| FY2023 | $1.2B | (1.12%) |
| FY2022 | $1.3B | 3.64% |
| FY2021 | $1.2B | 68.29% |
| FY2020 | $719.0M | (32.87%) |
| FY2019 | $1.1B | 238.92% |
| FY2018 | $316.0M | (53.80%) |
| FY2017 | $684.0M | 48.05% |
| FY2016 | $462.0M | 15.21% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jul 2026 | $362.0M | 6.78% |
| Apr 2026 | $339.0M | 11.15% |
| Jan 2026 | $305.0M | (29.72%) |
| Oct 2025 | $434.0M | 29.17% |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| A Agilent Technologies, Inc. | $1.4B |
| IQV IQVIA Holdings Inc. compare | $1.4B |
| IDXX IDEXX Laboratories, Inc. compare | $1.1B |
| DGX Quest Diagnostics Incorporated compare | $1.1B |
| LH Labcorp Holdings Inc. compare | $1.0B |
| MTD Mettler-Toledo International, Inc. compare | $905.6M |
| ILMN Illumina, Inc. compare | $824.0M |
| WAT Waters Corporation compare | $166.6M |
| NTRA Natera, Inc. compare | −$192.3M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on A
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement